Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China · Delayed Price · Currency is CNY 13.74
-0.01 (-0.07%)
Sep 29, 2025, 1:45 PM CST
Yifan Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 5,140 | 5,140 | 4,044 | 3,819 | 4,379 | 5,369 | Upgrade |
Other Revenue | 22.54 | 20.29 | 23.61 | 17.51 | 30.45 | 31.39 | Upgrade |
| 5,163 | 5,160 | 4,068 | 3,837 | 4,409 | 5,400 | Upgrade | |
Revenue Growth (YoY) | 8.55% | 26.84% | 6.03% | -12.98% | -18.36% | 4.12% | Upgrade |
Cost of Revenue | 2,785 | 2,808 | 2,159 | 1,983 | 2,594 | 2,899 | Upgrade |
Gross Profit | 2,377 | 2,352 | 1,909 | 1,853 | 1,815 | 2,501 | Upgrade |
Selling, General & Admin | 1,618 | 1,629 | 1,503 | 1,435 | 1,297 | 1,111 | Upgrade |
Research & Development | 296 | 291.97 | 312.38 | 190.2 | 196.64 | 325.34 | Upgrade |
Other Operating Expenses | 118.53 | 43.52 | 32.37 | 27.05 | 37.24 | 42.11 | Upgrade |
Operating Expenses | 2,063 | 2,026 | 1,908 | 1,682 | 1,552 | 1,487 | Upgrade |
Operating Income | 314.12 | 326.09 | 1.09 | 171.35 | 262.68 | 1,014 | Upgrade |
Interest Expense | -61.48 | -69.1 | -75.55 | -85.85 | -74.59 | -71.07 | Upgrade |
Interest & Investment Income | 9.24 | 8.12 | 13.13 | 21.39 | 25.3 | 33.21 | Upgrade |
Currency Exchange Gain (Loss) | 6.05 | -2.94 | 14.5 | 50.19 | -17.77 | -18.06 | Upgrade |
Other Non Operating Income (Expenses) | -11 | -7.66 | -14.84 | -12.38 | -8.03 | -3.06 | Upgrade |
EBT Excluding Unusual Items | 256.93 | 254.51 | -61.68 | 144.69 | 187.59 | 954.93 | Upgrade |
Impairment of Goodwill | - | - | - | - | -11.9 | - | Upgrade |
Gain (Loss) on Sale of Investments | -27.71 | -14.16 | -15.06 | -17.63 | -4.49 | -0.01 | Upgrade |
Gain (Loss) on Sale of Assets | 31.81 | 30.15 | 2.57 | -0.56 | 14.83 | -0.04 | Upgrade |
Asset Writedown | -14.9 | -11.48 | -852.58 | -102.13 | -26.34 | -6.6 | Upgrade |
Other Unusual Items | 193.2 | 129.65 | 57.71 | 132.37 | 51.1 | 132.44 | Upgrade |
Pretax Income | 439.33 | 388.66 | -869.03 | 156.74 | 210.79 | 1,081 | Upgrade |
Income Tax Expense | 44 | 65.04 | 16.62 | 29.65 | -31.42 | 149.32 | Upgrade |
Earnings From Continuing Operations | 395.33 | 323.62 | -885.65 | 127.09 | 242.21 | 931.39 | Upgrade |
Minority Interest in Earnings | 41.06 | 62.35 | 334.58 | 64.13 | 36.18 | 37 | Upgrade |
Net Income | 436.39 | 385.97 | -551.07 | 191.22 | 278.4 | 968.39 | Upgrade |
Net Income to Common | 436.39 | 385.97 | -551.07 | 191.22 | 278.4 | 968.39 | Upgrade |
Net Income Growth | - | - | - | -31.31% | -71.25% | 7.19% | Upgrade |
Shares Outstanding (Basic) | 1,211 | 1,206 | 1,225 | 1,195 | 1,210 | 1,210 | Upgrade |
Shares Outstanding (Diluted) | 1,211 | 1,206 | 1,225 | 1,275 | 1,210 | 1,226 | Upgrade |
Shares Change (YoY) | -1.09% | -1.51% | -3.94% | 5.32% | -1.26% | 0.40% | Upgrade |
EPS (Basic) | 0.36 | 0.32 | -0.45 | 0.16 | 0.23 | 0.80 | Upgrade |
EPS (Diluted) | 0.36 | 0.32 | -0.45 | 0.15 | 0.23 | 0.79 | Upgrade |
EPS Growth | - | - | - | -34.78% | -70.89% | 6.76% | Upgrade |
Free Cash Flow | 163.08 | 12.57 | -155.5 | -70.21 | -270.51 | 392.8 | Upgrade |
Free Cash Flow Per Share | 0.14 | 0.01 | -0.13 | -0.06 | -0.22 | 0.32 | Upgrade |
Dividend Per Share | 0.100 | 0.200 | - | - | - | 0.050 | Upgrade |
Dividend Growth | - | - | - | - | - | -50.00% | Upgrade |
Gross Margin | 46.05% | 45.59% | 46.93% | 48.30% | 41.16% | 46.31% | Upgrade |
Operating Margin | 6.08% | 6.32% | 0.03% | 4.47% | 5.96% | 18.77% | Upgrade |
Profit Margin | 8.45% | 7.48% | -13.55% | 4.98% | 6.31% | 17.93% | Upgrade |
Free Cash Flow Margin | 3.16% | 0.24% | -3.82% | -1.83% | -6.13% | 7.27% | Upgrade |
EBITDA | 642.14 | 642.69 | 253.66 | 379.13 | 453.82 | 1,191 | Upgrade |
EBITDA Margin | 12.44% | 12.46% | 6.24% | 9.88% | 10.29% | 22.05% | Upgrade |
D&A For EBITDA | 328.01 | 316.6 | 252.57 | 207.78 | 191.14 | 177.01 | Upgrade |
EBIT | 314.12 | 326.09 | 1.09 | 171.35 | 262.68 | 1,014 | Upgrade |
EBIT Margin | 6.08% | 6.32% | 0.03% | 4.47% | 5.96% | 18.77% | Upgrade |
Effective Tax Rate | 10.01% | 16.73% | - | 18.92% | - | 13.82% | Upgrade |
Revenue as Reported | 5,163 | 5,160 | 4,068 | 3,837 | 4,409 | 5,400 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.